MWN109 4

DRUG3 trials

Sponsors

Shanghai Minwei Biotechnology Co., Ltd

Conditions

Overweight , ObesityType 2 Diabetes Mellitus (T2DM)

Phase 1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

CompletedNCT07787728

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2025-07-14End: 2025-12-16Updated: 2026-08-28

Phase 2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

CompletedNCT07791524

Shanghai Minwei Biotechnology Co., LtdOverweight , Obesity

Start: 2026-01-05End: 2026-07-09Updated: 2026-08-28

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus

RecruitingNCT07801820

Shanghai Minwei Biotechnology Co., LtdType 2 Diabetes Mellitus (T2DM)

Start: 2026-06-23End: 2027-03-01Target: 240Updated: 2026-09-09